-
1تقرير
المصدر: Phase I Trial of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection
الوصول الحر: https://clinicaltrials.gov/show/NCT02822079Test
-
2تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
الوصول الحر: https://clinicaltrials.gov/show/NCT01595048Test
-
3تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (NSC# 606869) in the Very High Risk Stratum
الوصول الحر: https://clinicaltrials.gov/show/NCT01406756Test
-
4تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: Phase I Study of the Combination of the VEGFR Inhibitor, AZD2171, and MEK Inhibitor, AZD6244, in the Treatment of Solid Malignancies
الوصول الحر: https://clinicaltrials.gov/show/NCT02876068Test
-
5تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
الوصول الحر: https://clinicaltrials.gov/show/NCT02166385Test
-
6تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: Pharmacokinetic-Driven Individualization of Pazopanib Therapy in Patients With Solid Tumors: A Phase I Study
الوصول الحر: https://clinicaltrials.gov/show/NCT02706366Test
-
7تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: Phase 1 Clinical Trial of a Novel CDK Inhibitor Dinaciclib (SCH 727965) in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
الوصول الحر: https://clinicaltrials.gov/show/NCT02668731Test
-
8تقرير
المؤلفون: National Cancer Institute (NCI), NRG Oncology
المصدر: Randomized Phase II Trial of Concurrent Bevacizumab and Re-irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
الوصول الحر: https://clinicaltrials.gov/show/NCT02671981Test
-
9تقرير
المؤلفون: National Cancer Institute (NCI), NRG Oncology
المصدر: Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
الوصول الحر: https://clinicaltrials.gov/show/NCT02673190Test
-
10تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: A Phase II Study of GW 786034 (Pazopanib) in Advanced Thyroid Cancer
الوصول الحر: https://clinicaltrials.gov/show/NCT02653053Test
